+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pulmonary Drug Delivery Devices Market Research Report by Product Type, Application, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968897
  • Report
  • April 2022
  • Region: Global
  • 188 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Aerogen
  • Boehringer Ingelheim Gmbh
  • Celares GmbH
  • GF Health Products, Inc.
  • GlaxoSmithKline Plc
  • Koninklijke Philips N.V.
The Global Pulmonary Drug Delivery Devices Market size was estimated at USD 44.82 billion in 2021, USD 47.34 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.81% to reach USD 62.91 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pulmonary Drug Delivery Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Dry Powder Inhaler, Metered Dose Inhaler, and Nebulizer.
  • Based on Application, the market was studied across Asthma, COPD, and Cystic Fibrosis.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies and Retail Pharmacy Stores.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pulmonary Drug Delivery Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pulmonary Drug Delivery Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pulmonary Drug Delivery Devices Market, including Aerogen, AstraZeneca Plc, Boehringer Ingelheim Gmbh, Briggs Healthcare, Inc., Celares GmbH, Cipla Inc, GF Health Products, Inc., Gilbert Technologies, GlaxoSmithKline Plc, Jabil Inc, Koninklijke Philips N.V., MannKind Corporation, Merck & Co., Inc., Mylan N.V., Novartis AG, Omron Corporation, Sunovion Pharmaceuticals Inc., and The 3M Company.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pulmonary Drug Delivery Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pulmonary Drug Delivery Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pulmonary Drug Delivery Devices Market?
4. What is the competitive strategic window for opportunities in the Global Pulmonary Drug Delivery Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Pulmonary Drug Delivery Devices Market?
6. What is the market share of the leading vendors in the Global Pulmonary Drug Delivery Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Pulmonary Drug Delivery Devices Market?
Frequently Asked Questions about the Global Pulmonary Drug Delivery Devices Market

What is the estimated value of the Global Pulmonary Drug Delivery Devices Market?

The Global Pulmonary Drug Delivery Devices Market was estimated to be valued at $44.8 Billion in 2021.

What is the growth rate of the Global Pulmonary Drug Delivery Devices Market?

The growth rate of the Global Pulmonary Drug Delivery Devices Market is 5.8%, with an estimated value of $62.9 Billion by 2027.

What is the forecasted size of the Global Pulmonary Drug Delivery Devices Market?

The Global Pulmonary Drug Delivery Devices Market is estimated to be worth $62.9 Billion by 2027.

Who are the key companies in the Global Pulmonary Drug Delivery Devices Market?

Key companies in the Global Pulmonary Drug Delivery Devices Market include Aerogen, AstraZeneca Plc, Boehringer Ingelheim Gmbh, Briggs Healthcare, Inc., Celares GmbH, Cipla Inc, GF Health Products, Inc., Gilbert Technologies and Jabil Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aerogen
  • Boehringer Ingelheim Gmbh
  • Celares GmbH
  • GF Health Products, Inc.
  • GlaxoSmithKline Plc
  • Koninklijke Philips N.V.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of chronic respiratory diseases globally
5.1.1.2. Surge in use of development of digital or smart inhalers
5.1.1.3. Increasing shift toward pulmonary drug delivery devices as alternate route
5.1.2. Restraints
5.1.2.1. Issues concerned with price and regulations
5.1.3. Opportunities
5.1.3.1. Emerging technological advancements in pulmonary devices
5.1.3.2. Increasing healthcare expenditure on therapeutic devices
5.1.4. Challenges
5.1.4.1. Difficulty in maintenance due to deposition of aerosolized particles
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Pulmonary Drug Delivery Devices Market, by Product Type
6.1. Introduction
6.2. Dry Powder Inhaler
6.3. Metered Dose Inhaler
6.4. Nebulizer
7. Pulmonary Drug Delivery Devices Market, by Application
7.1. Introduction
7.2. Asthma
7.3. COPD
7.4. Cystic Fibrosis
8. Pulmonary Drug Delivery Devices Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacy Stores
9. Americas Pulmonary Drug Delivery Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pulmonary Drug Delivery Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Pulmonary Drug Delivery Devices Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Aerogen
13.2. AstraZeneca Plc
13.3. Boehringer Ingelheim Gmbh
13.4. Briggs Healthcare, Inc.
13.5. Celares GmbH
13.6. Cipla Inc
13.7. GF Health Products, Inc.
13.8. Gilbert Technologies
13.9. GlaxoSmithKline Plc
13.10. Jabil Inc
13.11. Koninklijke Philips N.V.
13.12. MannKind Corporation
13.13. Merck & Co., Inc.
13.14. Mylan N.V.
13.15. Novartis AG
13.16. Omron Corporation
13.17. Sunovion Pharmaceuticals Inc.
13.18. The 3M Company
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: DYNAMICS
FIGURE 2. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2027
FIGURE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, 2019-2027 (USD BILLION)
FIGURE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, 2019-2027 (USD BILLION)
FIGURE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 21. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD BILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 23. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 24. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, 2019-2027 (USD BILLION)
FIGURE 26. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 27. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 28. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 29. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 30. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 31. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 32. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 33. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 34. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: FPNV POSITIONING MATRIX
FIGURE 58. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 20. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2019-2027 (USD BILLION)
TABLE 21. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY STATE, 2019-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2019-2027 (USD BILLION)
TABLE 26. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY STATE, 2019-2027 (USD BILLION)
TABLE 28. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2019-2027 (USD BILLION)
TABLE 31. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY STATE, 2019-2027 (USD BILLION)
TABLE 33. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 36. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 37. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 39. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY REGION, 2019-2027 (USD BILLION)
TABLE 42. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 43. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY STATE, 2019-2027 (USD BILLION)
TABLE 44. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 47. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 48. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 49. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 50. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 51. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 52. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 53. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 54. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 55. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 56. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 57. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 58. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 59. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 60. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 61. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 62. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 63. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 65. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 66. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 67. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 71. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SCORES
TABLE 77. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: BUSINESS STRATEGY
TABLE 78. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: PRODUCT SATISFACTION
TABLE 79. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: RANKING
TABLE 80. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 81. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MERGER & ACQUISITION
TABLE 82. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 83. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 84. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: INVESTMENT & FUNDING
TABLE 85. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 86. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Aerogen
  • AstraZeneca Plc
  • Boehringer Ingelheim Gmbh
  • Briggs Healthcare, Inc.
  • Celares GmbH
  • Cipla Inc
  • GF Health Products, Inc.
  • Gilbert Technologies
  • GlaxoSmithKline Plc
  • Jabil Inc
  • Koninklijke Philips N.V.
  • MannKind Corporation
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Omron Corporation
  • Sunovion Pharmaceuticals Inc.
  • The 3M Company
Note: Product cover images may vary from those shown

Loading
LOADING...